Transvaginal dialysate leak via patent fallopian tubes following peritonitis in a CAPD patient Authors: Zhi Ying Tan, Abosede Bankole Published: 2026 ABSTRACT ABSTRACTTransvaginal leakage of peritoneal dialysate is an uncommon non-infectious complication of peritoneal dialysis (PD) and may be overlooked in female patients presenting with unexplained vaginal fluid loss. A 78-year-old woman with end-stage renal disease (ESRD) on continuous ambulatory peritoneal dialysis (CAPD) presented with a one-week history of clear per vaginal leakage. This episode developed following an initial presentation of PD peritonitis for which she was receiving antibiotic therapy. She reported the onset of clear vaginal leakage during a routine clinic visit for monitoring of her vancomycin level, prompting her admission for further evaluation. On clinical examination, the patient was afebrile and hemodynamically stable. Abdominal examination was satisfactory, however, speculum examination showed pooling of clear fluid in the vagina without evidence of vaginal or cervical pathology. Subsequent CT peritoneography demonstrated contrast-filled dialysate tracking from the peritoneal cavity, passing through bilaterally patent fallopian tubes into both the endometrial and vaginal cavities. Interestingly, there was no evidence of vaginal wall perforation or an abnormal fistulous connection identified. Given the absence of a correctable fistulous tract, PD was discontinued and the patient was transitioned to hemodialysis, resulting in complete resolution of symptoms. Although rare, physiological tubal patency can provide a conduit for dialysate leakage in PD patients, particularly following recent peritonitis. This mechanism is especially uncommon in post-menopausal women, highlighting the novelty of this case. Clinicians should maintain a high index of suspicion for this rare complication in women presenting with new-onset vaginal fluid loss. Early recognition and appropriate modality change may prevent recurrence. INTRODUCTION Peritoneal dialysis (PD) constitutes a renal replacement therapy for individuals with end-stage renal disease (ESRD), utilizing the peritoneum as the dialysis membrane. This technique involves the instillation of pre-packaged dialysate into the peritoneal cavity via a Tenckhoff catheter. PD is primarily administered through two modalities: continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). CAPD enables ongoing dialysis with three to five daily exchanges of dialysate using disposable bags, whereas APD employs larger fluid volumes that are instilled and drained automatically by a bedside machine [1]. Complications associated with PD encompass both infectious and non-infectious etiologies, including peritonitis, exit-site infections, intestinal or bladder perforation, hemorrhage, catheter flow obstruction, peri catheter leakage, and extrusion of the catheter cuff. Dialysate leakage is a major non-infectious complication with an overall reported incidence of 5–9.6% [2], which includes rare mechanical complication such as transvaginal leakage. Peritoneal dialysis fluid leakage into the pleural space, abdominal wall or via intestinal perforation into the pelvis are known complications of peritoneal dialysis [3]. However, transvaginal leak through normal functioning fallopian tubes is uncommon. While the fallopian tubes' role as conduits is recognized, the literature lacks documentation regarding the pathophysiological link between PD-related inflammation (e.g. peritonitis) and subsequent mechanical failure enabling fluid conduction through the utero-tubal pathway. Herein, we report a case involving transvaginal dialysate leak through the fallopian tubes a few days after commencing treatment for peritonitis. This presentation provides vital evidence refining the therapeutic approach for managing recurrence in inflammation-triggered tubal leakage. CASE PRESENTATION A 78-year-old Caucasian woman presented with a one-week history of intermittent per vaginal (PV) leakage of clear and odorless fluid. The leakage worsened on bending forward and standing upright. She denied abdominal pain, fever, or other systemic symptoms. She has a past medical history of hypertension and ESRD on CAPD for a year and 8 months. She was on 1.0 L fill volume four times a day with a dwell time of 4 hours for the day sessions and an overnight dwell of 12 hrs. She was on a fill volume of 1.0 L due to a low body weight of 46 kg and was still passing 400 mls of urine with recorded adequacy sample within the target range of KT/V 1.79 and creatinine clearance 59 ml/min. She had presented to the PD clinic 9 days prior with cloudy effluent in the PD bag. Her PD fluid white cell count was 1750 cells/μL with a heavy growth of Staphylococcus epidermidis. She was then commenced on intra-peritoneal vancomycin and oral ciprofloxacin for PD peritonitis. A repeat fluid analysis 4 days later showed improvement in white cell count but culture remained positive for S. epidermidis. She had developed worsening vaginal discharge around this period of time whilst on intraperitoneal vancomycin. Clinical examination was unremarkable except for the clear vaginal discharge. Blood tests (including inflammatory markers) and blood cultures were negative on admission. Treatment of PD peritonitis was ongoing at presentation and was continued pending further investigations. The patient had a prior history of peritonitis, diagnosed a month after commencement of peritoneal dialysis. She completed a course of ciprofloxacin and gentamicin with no further episode until the most recent presentation. Given the unusual presentation, she was referred to the gynecologist for further review due to the suspicion of peritoneo-vaginal/vesicovaginal fistula. Speculum examination revealed pooling of clear fluid in the vaginal canal, though no identifiable source of leakage was found. Vaginal swabs were unremarkable, and the radiology team was consulted for further imaging. Fluoroscopy-assisted CT peritoneography demonstrated a continuous tract of contrast enhanced dialysate from peritoneal cavity through patent fallopian tubes into the endometrial and vaginal cavities (Figures 1 and 2). There was no evidence of uterine or vaginal wall perforation, and no abnormal fistula formation. The findings were consistent with physiological patency of fallopian tubes serving as a conduit for dialysate leakage. The patient was already on a low volume CAPD and further volume reduction was not considered due to possibility of inefficient dialysis. Hence, she was transitioned to hemodialysis and her PD catheter was removed. Following this intervention, the PV leakage resolved completely, and no further episodes were reported. An overview of the patient's clinical course is shown in Figure 3]. Coronal segment of CT peritoneography displaying the flow of contrast from peritoneum to the uterus through the fallopian tube. Yellow arrows depict dialysate within the left and right fallopian tubes. Sagittal segment of CT peritoneography displaying the presence of contrast material within the uterus. Red arrows depict dialysate within the uterus and the posterior fornix of the vagina. Timeline of patient's clinical progression. DISCUSSION CAPD patients are particularly susceptible to complications relating to elevated intraperitoneal pressure, such as hernia formation, genital oedema, and dialysate leakage [2]. In rare instances, peritoneal fluid may escape via the fallopian tubes into the uterus and vagina [4], or through a fistulous tract between the peritoneal cavity and the uterus or vagina. This case report highlights that dialysate leakage may also occur via the fallopian tubes in the context of otherwise normal genitourinary anatomy. The differential diagnosis for abnormal vaginal discharge is broad and includes infectious causes (e.g., bacterial vaginosis, cervicitis, etc.), retained foreign bodies, and pathological fistulas. In this instance, sexual inactivity reduced the likelihood of infection, and examination by a gynecologist excluded the presence of retained foreign objects, such as tampons or pessaries. Prior peritonitis may provoke acute and chronic inflammatory changes within pelvic structures, including the fallopian tubes, potentially increasing tissue friability and altering normal barriers to fluid passage. In one case of peritoneal dialysis complication, pathological examination revealed inflammation of the fallopian tube in the context of vaginal dialysate leakage, supporting this mechanism [5]. Although that case does not establish inflammation of the fallopian tube as an isolated cause of vaginal dialysate leakage, it supports the proposed mechanism that inflammatory damage to tubal structures may compromise normal anatomic and pressure barriers, facilitating abnormal translocation of peritoneal fluid. In this case, there was no clinical or radiological evidence of alternative systemic inflammatory processes, such as underlying inflammatory bowel disease or malignancy, suggesting that prior peritonitis may have been the predominant contributing factor to the development of vaginal dialysate leakage in this patient. PD fluid leakage can manifest externally at the catheter exit site or internally via anatomical communications. External leaks are readily identified at bedside using urine dipstick testing, as high glucose content indicates content of dialysate. Additionally, urine dipsticks may support the diagnosis of PD-related peritonitis by detecting nitrites and leukocytes. Internal leaks, by contrast, are more challenging to localize and often require imaging to confirm. Initial assessment of a patient presenting with vaginal discharge requires a thorough clinical history and physical examination, including speculum evaluation by a gynecologist. If the diagnosis remains unclear, further investigations are warranted. CT peritoneography remains the imaging modality of choice due to its practicality, accessibility, and ability to provide comprehensive assessment of the peritoneal cavity. The procedure involves injecting iodinated contrast into the dialysate through the patient's PD catheter allowing visualization of the peritoneal space and potential sites of leakages. Magnetic resonance imaging (MRI) peritoneography can also be performed using gadolinium-based contrast e.g. gadopentetate dimeglumine instilled into the peritoneal cavity, offering detailed assessment of dialysate leaks as an alternative to iodinated contrast and ionizing radiation [6]. In this case, CT peritoneography demonstrated contrast filling the peritoneum, progressing bilaterally through the fallopian tubes (Figure 1), and reaching the endometrial cavity and vaginal vault (Figure 2). These findings indicate patency between the peritoneal cavity and fallopian tubes, permitting drainage into the endometrial and vaginal cavities, thus explaining the patient's symptoms. There was no evidence of peritoneal-vaginal or vesicovaginal fistula. These findings confirm a physiological, rather than pathological, route of dialysate passage—one made possible by the persistent patency of the fallopian tubes. Current data guiding the management of peritoneo-vaginal leaks are limited, and much of the guidance is extrapolated from experiences with other types of dialysate leakage. Several treatment modalities for dialysate leaks have been advocated, including surgical repair, temporary transfer to hemodialysis (HD), and supine APD with small volumes (500 to 1500 ml) leaving the peritoneal cavity empty during ambulatory periods [7,8]. According to literature, dialysate leaks are arbitrarily classified as early (<30 days) or late (>30 days), following catheter implantation and the start of PD [7]. For early leaks, temporary cessation of dialysis for 1 to 3 weeks generally results in spontaneous cessation of the leak, with surgical intervention reserved for cases of recurrence [7-9]. For late leaks, HD or surgery are treatment options, although surgical treatment has been suggested to offer longer remission periods without recurrence [8,9]. In this patient, bilateral tubal ligation was considered as a treatment option. However, given the absence of a pathological fistula and the patient's age and dialysis history, a decision was made to permanently discontinue PD. She was transitioned to HD, and her PD catheter was removed. Following this, the vaginal leakage resolved completely. CONCLUSION This case underscores a rare but important complication of PD—transvaginal dialysate leakage via anatomically intact fallopian tubes. Although uncommon, such presentations should be considered in female PD patients with unexplained vaginal fluid loss, particularly in the context of peritonitis. A multidisciplinary approach involving nephrology, gynecology, and radiology is essential for timely diagnosis and management. CT peritoneography remains the imaging modality of choice for delineating anatomical pathways of dialysate leakage. In selected cases, transition to HD may be necessary to resolve symptoms and prevent recurrence. Declaration of competing interest The authors declare no conflict of interest. Consent for publication Written informed consent was obtained from the patient to publish this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Funding Nothing to declare.